News summary

Ferring moves to acquire Gameto in $1.38b deal

Source: Longevity Technology • Published: 27 Oct 2026, 16:06

Summarized by Masters of Longevity from Longevity Technology.

Ferring agreed to buy Gameto, which engineers ovarian support cells.

Ferring moves to acquire Gameto in $1.38b deal
Key Takeaways
  • Deal value is contingent on development and commercial milestones.
  • Fertilo is investigational and has not yet won FDA approval.
  • Ovarian aging benefits remain unproven and require long study.
Read the full article at Longevity Technology ↗

Continue exploring

Recommended MoL Picks

MoL PickApple Brings Longevity to the Wrist. What Will It Change?Apple’s new Health Age, readiness and movement tools bring long-term health into everyday view. The opportunity is turning that information into useful action.MoL PickSeed Oils and Health: Inflammation, Processing and EvidenceHuman trials, processing risks and long-term health ask different questions. What can seed-oil research tell us—and what remains unresolved?MoL PickMOTS-c: Where the Evidence EndsStudies offer clues about ageing and metabolism. What do they actually tell us about human health—and where does expert opinion take over?